[Leukocyte depletion of blood products: a requirement for improvement of quality and safety].
De Pauw
B E
BE
Van den Bos
A
A
D001771:Blood Banks / Q000191:economics / Q000592:standards / Q000639:trends*; D001781:Blood Component Removal / Q000009:adverse effects* / Q000191:economics / Q000379:methods; D001803:Blood Transfusion / Q000592:standards*; D003257:Consumer Product Safety / Q000592:standards*; D003362:Cost-Benefit Analysis; D006801:Humans; D007962:Leukocytes / Q000276:immunology* / Q000821:virology; D009426:Netherlands